Hormone-sensitive lipase - New roles for an old enzyme

被引:185
作者
Yeaman, Stephen J. [1 ]
机构
[1] Sch. of Cell and Molec. Biosciences, Medical School, University of Newcastle
关键词
β-cell; Cholesterol metabolism; Hormone-sensitive lipase; Lipolysis; Macrophage; Perilipin;
D O I
10.1042/BJ20031811
中图分类号
学科分类号
摘要
Although described initially as an intracellular adipocyte-specific triacylglycerol lipase, it is now clear that HSL (hormone-sensitive lipase) is expressed in multiple tissues and plays a number of roles in lipid metabolism, including that of a neutral cholesteryl ester hydrolase. The major isoform is a single polypeptide with a moleclar mass of approx. 84 kDa and which comprises three major domains: a catalytic domain, a regulatory domain encoding several phosphorylation sites and an N-terminal domain involved in protein-protein and protein-lipid interactions. The activity of HSL is regulated acutely by several mechanisms, including reversible phosphorylation by a number of different protein kinases, translocation to different sites within the cell and interaction with a number of proteins, some of which may serve to direct the inhibitory products of HSL away from the protein. It is also apparent from work with HSL null mice that more than one enzyme species may be classified as a hormone-sensitive lipase. The possible presence of HSL in macrophages remains controversial, and the role of the protein in pancreatic β-cells has yet to be fully elucidated. Altered expression of HSL in different cell types may be associated with a number of pathological states, including obesity, atherosclerosis and Type II diabetes.
引用
收藏
页码:11 / 22
页数:11
相关论文
共 145 条
  • [81] Ray H., Beylot M., Arner P., Larrouy D., Langin D., Holm C., Large V., The presence of a catalytically inactive form of hormone-sensitive lipase is associated with decreased lipolysis in abdominal subcutaneous adipose tissue of obese subjects, Diabetes, 52, pp. 1417-1422, (2003)
  • [82] Osuga J., Ishibashi S., Oka T., Yagyu H., Tozawa R., Fujimoto A., Shionoiri F., Yahagi N., Kraemer F.B., Tsutsumi O., Yamada N., Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not obesity, Proc. Natl. Acad. Sci. U.S.A., 97, pp. 787-792, (2000)
  • [83] Wang S.P., Laurin N., Himms-Hagen J., Rudnicki M.A., Levy E., Robert M.-F., Pan L., Oligny L., Mitchell G.A., The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice, Obes. Res., 9, pp. 119-128, (2001)
  • [84] Haemmerle G., Zimmermann R., Hayn M., Theussl C., Waeg G., Wagner E., Sattler W., Magin T.M., Wagner E.F., Zechner R., Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle and testis, J. Biol. Chem., 277, pp. 4806-4815, (2002)
  • [85] Raclot T., Holm C., Langin D., Fatty acid specificity of hormone-sensitive lipase: Implications in the selective hydrolysis of triacylglycerols, J. Lipid Res., 42, pp. 2049-2057, (2001)
  • [86] Okazaki H., Osuga J., Tamura Y., Yahagi N., Tomita S., Shionoiri F., Iizuka Y., Ohashi K., Harada K., Kimura S., Et al., Lipolysis in the absence of hormone-sensitive lipase. Evidence for a common mechanism regulating distinct lipases, Diabetes, 51, pp. 3368-3375, (2002)
  • [87] Kraemer F.B., Shen W.-J., Hormone-sensitive lipase: Control of intracellular tri-(di-)acylglycerol and cholesterol ester hydrolysis, J. Lipid Res., 43, pp. 1585-1594, (2002)
  • [88] Reynisdottir S., Eriksson M., Angelin B., Arner P., Impaired activation of adipocyte liolysis in familial combined hyperlipidemia, J. Clin. Invest., 95, pp. 2161-2169, (1995)
  • [89] Ylitalo K., Large V., Pajukanta P., Reynisdottir S., Porkka K.V.K., Vakkilainen J., Nuotio I., Taskinen M.-R., Arner P., Reduced hormone-sensitive lipase is not a major metabolic defect in Finnish FCHL, Atherosclerosis, 153, pp. 373-381, (2000)
  • [90] Montague C.T., O'Rahilly S., The perils of portliness. Causes and consequences of visceral adiposity, Diabetes, 49, pp. 883-888, (2000)